Encompass Health Declares Dividend on Common Stock

Rhea-AI Summary

Encompass Health (NYSE: EHC) has announced a quarterly cash dividend declaration by its board of directors. Shareholders will receive $0.17 per share as a cash dividend. The dividend will be paid on April 15, 2025, to stockholders who are registered as holders of record on April 1, 2025.

Positive

• Consistent dividend payment demonstrates financial stability
• Direct return of capital to shareholders through $0.17 per share dividend

Negative

• None.

BIRMINGHAM, Ala., Feb. 20, 2025 /PRNewswire/ -- Encompass Health Corporation (NYSE: EHC) today announced that its board of directors has declared a quarterly cash dividend on its common stock of $0.17 per share, payable on April 15, 2025, to holders of record on April 1, 2025.

About Encompass Health
Encompass Health (NYSE: EHC) is the largest owner and operator of inpatient rehabilitation hospitals in the United States. With a national footprint that includes 166 hospitals in 38 states and Puerto Rico, the Company provides high-quality, compassionate rehabilitative care for patients recovering from a major injury or illness, using advanced technology and innovative treatments to maximize recovery. Encompass Health is ranked as one of Fortune's World's Most Admired Companies™, Becker's Hospital Review's 150 Top Places to Work in Healthcare and Forbes' Most Trusted Companies in America. For more information, visit encompasshealth.com, or follow us on our newsroom, Twitter, Instagram and Facebook.

From Fortune. © 2025 Fortune Media IP Limited. All rights reserved. Fortune® is a registered trademark and Fortune World's Most Admired Companies™ is trademark of Fortune Media IP Limited and are used under license. Fortune and Fortune Media IP Limited are not affiliated with, and do not endorse products or services of, Encompass Health. From Forbes © 2024 Forbes Media LLC. All rights reserved. Used under license.

Forward-Looking Statements
Statements contained in this press release which are not historical facts, such as the timing and amounts of dividends, are forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995. In addition, Encompass Health, through its senior management, may from time to time make forward-looking public statements concerning the matters described herein. All such estimates, projections, and forward-looking statements speak only as of the date hereof, and Encompass Health undertakes no duty to publicly update or revise such forward-looking statements, whether as a result of new information, future events, or otherwise. Such forward-looking statements are necessarily estimates based upon current information and involve a number of risks and uncertainties. Actual events or results may differ materially from those anticipated in these forward-looking statements as a result of a variety of factors. While it is impossible to identify all such factors, factors which could cause actual events or results to differ materially from those estimated by Encompass Health include, but are not limited to, the legal, regulatory and administrative developments that occur at the federal, state and local levels; general conditions in the economy and capital markets, including any instability or uncertainty related to armed conflict, an act of terrorism or natural disaster, governmental impasse over approval of the United States federal budget, an increase in the debt ceiling, or an international sovereign debt crisis; Encompass Health's ability to comply with extensive, complex, and ever-changing regulations in the healthcare industry; potential disruptions, breaches, or other incidents affecting the proper operation, availability, or security of Encompass Health's or its vendors' or partners' information systems; changes, delays in (including in connection with resolution of Medicare payment reviews or appeals), or suspension of reimbursement for Encompass Health's services by governmental or private payors; and other factors which may be identified from time to time in Encompass Health's SEC filings and other public announcements, including Encompass Health's Form 10‑K for the year ended December 31, 2023 and Form 10-Q for the quarters ended March 31, 2024, June 30, 2024 and September 30, 2024.

Media contact:
Polly Manuel | 205-970-5912
media@encompasshealth.com

Investor Relations contact:
Mark Miller | 205-970-5860
mark.miller@encompasshealth.com   

View original content to download multimedia:https://www.prnewswire.com/news-releases/encompass-health-declares-dividend-on-common-stock-302381433.html

SOURCE Encompass Health Corp.

FAQ

What is the amount of Encompass Health's Q2 2025 dividend payment?

Encompass Health (EHC) declared a quarterly dividend of $0.17 per share for Q2 2025.

When is the ex-dividend date for Encompass Health's Q2 2025 dividend?

Shareholders must be holders of record by April 1, 2025, to receive the dividend payment.

When will Encompass Health (EHC) pay its Q2 2025 dividend?

The dividend payment will be made on April 15, 2025.

What is the annual dividend yield for Encompass Health based on the current quarterly payment?

Based on the quarterly dividend of $0.17, the annual dividend payment would be $0.68 per share, but the yield depends on the current stock price.